实体器官移植术后真菌感染的防治

邓斐文

doi:10.3969/j.issn.1674-7445.2022.04.006

实体器官移植术后真菌感染的防治

doi: 10.3969/j.issn.1674-7445.2022.04.006

邓斐文^,

528000 广东佛山，佛山市第一人民医院肝脏胰腺外科

基金项目:

广东省基础与应用基础研究基金联合基金重点项目 2020B1515120031

佛山市医学类科技攻关项目 2018AB003501

详细信息

作者简介:

通讯作者:
邓斐文，Email：dengfeiwen2012@163.com

中图分类号: R617, R379
计量
- 文章访问数: 370
- HTML全文浏览量: 248
- PDF下载量: 150
- 被引次数: 0
出版历程
- 收稿日期: 2022-03-21
- 网络出版日期: 2022-07-14
- 刊出日期: 2022-07-15

Prevention and treatment of fungal infection after solid organ transplantation

Deng Feiwen^,

Department of Hepatopancreas Surgery, the First People's Hospital of Foshan, Foshan 528000, China

More Information

Corresponding author: Deng Feiwen, Email: dengfeiwen2012@163.com

摘要

摘要: 经过近70年的发展，器官移植已经成为多种终末期疾病的有效治疗手段。但器官移植受者术后需服用免疫抑制剂，导致免疫功能低下，感染的发生率较高，包括病毒、细菌和真菌感染。其中真菌感染发病较隐蔽，早期诊断较困难，假丝酵母、曲霉、隐球菌、肺孢子菌感染是实体器官移植中比较常见的真菌感染。识别实体器官移植术后真菌感染的高危因素，提前预防，术后结合1，3-β-D葡聚糖试验（真菌G试验）、影像学检查和相关体液培养结果，做到早期诊断、早期治疗，对降低实体器官移植术后真菌感染的发生率及相关的病死率具有较大的临床意义。本文就器官移植术后常见的真菌感染进行综述，以期为器官移植术后真菌感染的防治提供参考。
- 器官移植 /
- 真菌感染 /
- 假丝酵母 /
- 曲霉 /
- 隐球菌 /
- 肺孢子菌 /
- 棘白菌素 /
- 两性霉素B
Abstract: Over nearly 70-year development, organ transplantation has become an effective treatment for multiple end-stage diseases. However, postoperative administration of immunosuppressants should be given for the recipients, which leads to low immune function and high incidence rate of infection, including viral, bacterial and fungal infections. Among them, the occurrence of fungal infection is hidden, and it is difficult to deliver prompt diagnosis. Candida, Aspergillus, Cryptococcus and Pneumocystis infection are common fungal infections in solid organ transplantation. High-risk factors of fungal infection after solid organ transplantation should be identified and prevented in advance, and prompt diagnosis and treatment should be carried out by combining the results of (1, 3)-β-D-glucan assay (fungal G-test), imaging examination and related body fluid culture. These interventions are of clinical significance to reduce the incidence of fungal infection and fatality after solid organ transplantation. In this article, common fungal infections after organ transplantation were reviewed, aiming to provide reference for the prevention and treatment of fungal infections after organ transplantation.
- Organ transplantation /
- Fungal infection /
- Candida /
- Aspergillus /
- Cryptococcus /
- Pneumocystis /
- Echinocandin /
- Amphotericin B

HTML全文

下载: 全尺寸图片幻灯片

参考文献(34)

[1]	MURRAY JE. The 50th anniversary of the first successful human organ transplant[J]. Rev Invest Clin, 2005, 57(2): 118-119.
[2]	RAKELA J, FUNG JJ. Thomas E. Starzl, M.D., Ph. D. (1926-2017)[J]. Hepatology, 2017, 66(1): 306-308. DOI: 10.1002/hep.29214.
[3]	NANAYAKKARA DD, SCHAENMAN J. Screening of donors and recipients for infections prior to solid organ transplantation[J]. Curr Opin Organ Transplant, 2019, 24(4): 456-464. DOI: 10.1097/MOT.0000000000000671.
[4]	魏绪霞, 易慧敏. 器官移植供者来源性感染防治的研究进展[J]. 器官移植, 2020, 11(1): 115-120. DOI: 10.3969/j.issn.1674-7445.2020.01.019. WEI XX, YI HM. Research progress on prevention and treatment of donor-derived infection in organ transplantation[J]. Organ Transplant, 2020, 11(1): 115-120. DOI: 10.3969/j.issn.1674-7445.2020.01.019.
[5]	张坚磊. 实体器官移植受者侵袭性真菌感染的实验室诊断[J/CD]. 实用器官移植电子杂志, 2018, 6(3): 234-239. DOI: 10.3969/j.issn.2095-5332.2018.03.020. ZHANG JL. Laboratory diagnosis of invasive fungal infection in solid organ transplant recipients[J/CD]. Pract J Organ Transplant (Electr Vers), 2018, 6(3): 234-239. DOI: 10.3969/j.issn.2095-5332.2018.03.020.
[6]	NEOFYTOS D, GARCIA-VIDAL C, LAMOTH F, et al. Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response[J]. BMC Infect Dis, 2021, 21(1): 296. DOI: 10.1186/s12879-021-05958-3.
[7]	PAPPAS PG, ALEXANDER BD, ANDES DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)[J]. Clin Infect Dis, 2010, 50(8): 1101-1111. DOI: 10.1086/651262.
[8]	ANDES DR, SAFDAR N, BADDLEY JW, et al. The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)[J]. Transpl Infect Dis, 2016, 18(6): 921-931. DOI: 10.1111/tid.12613.
[9]	刘琳, 王慧, 刘宁宁. 侵袭性念珠菌感染在免疫力低下人群中的流行病学和治疗进展[J]. 上海交通大学学报(医学版), 2021, 41(4): 525-529. DOI: 10.3969/j.issn.1674-8115.2021.04.018. LIU L, WANG H, LIU NN. Advances in epidemiology and treatment of invasive Candida infection in the immunocompromised population[J]. J Shanghai Jiaotong Univ (Med Sci), 2021, 41(4): 525-529. DOI: 10.3969/j.issn.1674-8115.2021.04.018.
[10]	ASLAM S, ROTSTEIN C, AST Infectious Disease Community of Practice. Candida infections in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13623. DOI: 10.1111/ctr.13623.
[11]	CLANCY CJ, NGUYEN MH. Diagnosing invasive candidiasis[J]. J Clin Microbiol, 2018, 56(5): e01909-e01917. DOI: 10.1128/JCM.01909-17.
[12]	KABIR V, MAERTENS J, KUYPERS D. Fungal infections in solid organ transplantation: an update on diagnosis and treatment[J]. Transplant Rev (Orlando), 2019, 33(2): 77-86. DOI: 10.1016/j.trre.2018.12.001.
[13]	HOU TY, WANG SH, LIANG SX, et al. The screening performance of serum 1, 3-Beta-D-glucan in patients with invasive fungal diseases: a Meta-analysis of prospective cohort studies. [J] PLoS One, 2015, 10(7): e0131602. DOI: 10.1371/journal.pone.0131602.
[14]	LIU M, ZHU Z, SUN L. Risk factors of invasive fungal infection in recipients after liver transplantation: a systematic review and Meta-analysis[J]. Front Med (Lausanne), 2021, 8: 687028. DOI: 10.3389/fmed.2021.687028.
[15]	PHOOMPOUNG P, HERRERA S, PÉREZ CORTÉS VILLALOBOS A, et al. Risk factors of invasive fungal infections in liver transplant recipients: a systematic review and Meta-analysis[J]. Am J Transplant, 2022, 22(4): 1213-1229. DOI: 10.1111/ajt.16935.
[16]	SILVA JT, SAN-JUAN R, FERNÁNDEZ-CAAMAÑO B, et al. Infectious complications following small bowel transplantation[J]. Am J Transplant, 2016, 16(3): 951-959. DOI: 10.1111/ajt.13535.
[17]	HUSAIN S, CAMARGO JF. Invasive aspergillosis in solid-organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13544. DOI: 10.1111/ctr.13544.
[18]	JU C, LIAN Q, XU X, et al. Epidemiology and prognosis of invasive fungal disease in Chinese lung transplant recipients[J]. Front Med (Lausanne), 2021, 8: 718747. DOI: 10.3389/fmed.2021.718747.
[19]	中华医学会器官移植学分会. 器官移植受者侵袭性真菌病临床诊疗技术规范(2019版)[J]. 器官移植, 2019, 10(3): 227-236. DOI: 10.3969/j.issn.1674-7445.2019.03.002 Branch of Organ Transplantation of Chinese Medical Association. Technical specifcation for clinical diagnosis and treatment for invasive fungal disease in organ transplant recipients (2019 edition)[J]. Organ Transplant, 2019, 10(3): 227-236. DOI: 10.3969/j.issn.1674-7445.2019.03.002
[20]	NEOFYTOS D, CHATZIS O, NASIOUDIS D, et al. Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study[J]. Transpl Infect Dis, 2018, 20(4): e12898. DOI: 10.1111/tid.12898.
[21]	HUSAIN S, SILVEIRA FP, AZIE N, et al. Epidemiological features of invasive mold infections among solid organ transplant recipients: PATH Alliance^® registry analysis[J]. Med Mycol, 2017, 55(3): 269-277. DOI: 10.1093/mmy/myw086.
[22]	PÉREZ-JACOISTE ASÍN MA, LÓPEZ-MEDRANO F, FERNÁNDEZ-RUIZ M, et al. Risk factors for the development of invasive aspergillosis after kidney transplantation: systematic review and Meta-analysis[J]. Am J Transplant, 2021, 21(2): 703-716. DOI: 10.1111/ajt.16248.
[23]	CHULEERARUX N, THONGKAM A, MANOTHUMMETHA K, et al. Does post-transplant cytomegalovirus increase the risk of invasive aspergillosis in solid organ transplant recipients? a systematic review and Meta-analysis[J]. J Fungi (Basel), 2021, 7(5): 327. DOI: 10.3390/jof7050327.
[24]	PATTERSON TF, THOMPSON GR 3RD, DENNING DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2016, 63(4): e1-e60. DOI: 10.1093/cid/ciw326.
[25]	ULLMANN AJ, AGUADO JM, ARIKAN-AKDAGLI S, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline[J]. Clin Microbiol Infect, 2018, 24(Suppl 1): e1-e38. DOI: 10.1016/j.cmi.2018.01.002.
[26]	SAMANTA P, CLANCY CJ, NGUYEN MH. Fungal infections in lung transplantation[J]. J Thorac Dis, 2021, 13(11): 6695-6707. DOI: 10.21037/jtd-2021-26.
[27]	GEORGE IA, SANTOS CAQ, OLSEN MA, et al. Epidemiology of cryptococcosis and cryptococcal meningitis in a large retrospective cohort of patients after solid organ transplantation[J]. Open Forum Infect Dis, 2017, 4(1): ofx004. DOI: 10.1093/ofid/ofx004.
[28]	BADDLEY JW, FORREST GN, AST Infectious Diseases Community of Practice. Cryptococcosis in solid organ transplantation-guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13543. DOI: 10.1111/ctr.13543.
[29]	PERFECT JR, BICANIC T. Cryptococcosis diagnosis and treatment: what do we know now[J]. Fungal Genet Biol, 2015, 78: 49-54. DOI: 10.1016/j.fgb.2014.10.003.
[30]	WALD-DICKLER N, SHE R, BLODGET E. Cryptococcal disease in the solid organ transplant setting: review of clinical aspects with a discussion of asymptomatic cryptococcal antigenemia[J]. Curr Opin Organ Transplant, 2017, 22(4): 307-313. DOI: 10.1097/MOT.0000000000000426.
[31]	FISHMAN JA, GANS H, AST Infectious Diseases Community of Practice. Pneumocystis jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13587. DOI: 10.1111/ctr.13587.
[32]	PERMPALUNG N, KITTIPIBUL V, MEKRAKSAKIT P, et al. A comprehensive evaluation of risk factors for pneumocystis jirovecii pneumonia in adult solid organ transplant recipients: a systematic review and Meta-analysis[J]. Transplantation, 2021, 105(10): 2291-2306. DOI: 10.1097/TP.0000000000003576.
[33]	BRAKEMEIER S, PFAU A, ZUKUNFT B, et al. Prophylaxis and treatment of pneumocystis jirovecii pneumonia after solid organ transplantation[J]. Pharmacol Res, 2018, 134: 61-67. DOI: 10.1016/j.phrs.2018.06.010.
[34]	MILLER R, ASSI M, AST Infectious Diseases Community of Practice. Endemic fungal infections in solid organ transplant recipients-guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13553. DOI: 10.1111/ctr.13553.